NMRA Neumora Therapeutics, Inc.
Company Analysis
Latest News
🟢 Neumora Therapeutics is trading 17% up today — no definitive catalyst identified
Neumora Therapeutics is trading at $0.81, up 17.07%, with no definitive catalyst identified for the September 22, 2026 move. - No clear company-specific...
🟢 Neumora Therapeutics is trading 6.3% up today
Neumora Therapeutics is trading at $0.74 (+6.30%) during the September 22, 2026 session; no clear company-specific announcement or fresh catalyst was...
🟢 Neumora Therapeutics is trading 8% up in pre-market with no clear company-specific catalyst identified
Neumora Therapeutics is trading at $0.75, up 7.81% after closing at $0.69 on September 21, 2026. - No clear company-specific announcement or overnight...
🔴 Neumora Therapeutics is trading 5.18% down in after-hours trading with no clear company-specific catalyst identified
Neumora Therapeutics is trading 5.18% down in after-hours trading at $0.69 after no clear company-specific catalyst was identified for September 21, 2026. -...
🔴 Neumora Therapeutics is trading 5.18% down today as catalyst remains unclear
Neumora Therapeutics is trading at $0.69, down 5.18% on September 21, 2026, extending a sharp multi-session decline with no clear catalyst identified. -...
🟢 Neumora Therapeutics is trading 12.33% up in pre-market as U.S. equities gain
Neumora Therapeutics is trading at $0.82, up 12.33%, after broader risk-on sentiment lifted U.S. equities on September 21, 2026. • S&P 500 and Nasdaq...
🟢 Neumora Therapeutics is trading 6.99% up in pre-market as S&P 500 and Nasdaq Composite rise
Neumora Therapeutics is trading up 6.99% at $0.78 in pre-market as broader risk-on sentiment supports the move. - S&P 500 is up 0.68%, while Nasdaq Composite...
🔴 Neumora Therapeutics is trading 5.3% down today with no clear company-specific catalyst
Neumora Therapeutics is trading at $0.71 (-5.28%), with no clearly reported company-specific announcement explaining the September 18, 2026 decline. -...
🟢 Neumora Therapeutics is trading 6.67% up in pre-market with no clear fresh company-specific catalyst
Neumora Therapeutics is trading 6.67% up now at $0.80, with no fresh company-specific announcement or earnings release clearly explaining the pre-market...
🟢 Neumora Therapeutics is trading 8% up in after-hours trading — no clear catalyst identified
Neumora Therapeutics is trading 8% up now at $0.81 after closing September 17, 2026 at $0.75, with no fresh company-specific announcement or earnings release...
🔴 Neumora Therapeutics is trading 5.34% down today
Neumora Therapeutics is trading at $0.73, down 5.34%, extending recent weakness despite a broader September 17, 2026 market and biotech-sector rally. - No...
🟢 Neumora Therapeutics is trading 8.64% up in pre-market amid global market recovery
Neumora Therapeutics is trading 8.64% up at $0.84, with no fresh company-specific catalyst identified for September 17, 2026; the move appears primarily tied...
🔴 Neumora Therapeutics is trading 5.65% down today as biotech stocks weaken
Neumora Therapeutics is trading 5.65% down at $0.78 on September 16, 2026, with the move appearing primarily sector-driven amid broader biotech weakness. - The...
🟢 Neumora Therapeutics is trading 6.34% up today after recent selloff
Neumora Therapeutics is trading 6.34% up at $0.88, with the rebound appearing to follow the recent selloff rather than a confirmed corporate catalyst. -...
🔴 Neumora Therapeutics is trading 10.35% down today amid biotech weakness after disappointing Ionis trial news
Neumora Therapeutics is trading 10.35% down at $0.90 after broader biotech weakness intensified following disappointing clinical-trial news from Ionis...
🔴 Neumora Therapeutics falls 5.7% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🔴 Neumora Therapeutics is trading 10.53% down today as coverage points to failed Phase 3 depression trials
Neumora Therapeutics is trading $1.02 (-10.53%) lower, with no new company-specific announcement, earnings release, or analyst action clearly explaining the...
🔴 Neumora Therapeutics is trading 7.01% down today with no clear company-specific catalyst identified
Neumora Therapeutics is trading 7.01% down at $1.06, continuing a multiday decline from $1.33 on September 1, 2026, with no clear company-specific catalyst...
🔴 Neumora Therapeutics is trading 5% down today as hotter-than-expected August producer inflation weighs on markets
Neumora Therapeutics is trading 5% down at $1.14 as broader markets weaken following hotter-than-expected August producer inflation. - The S&P 500, Nasdaq...
🟢 Neumora Therapeutics is trading 16.81% up in pre-market — No clear company-specific catalyst identified
Neumora Therapeutics is trading 16.81% up now at $1.40 in pre-market, with no clearly reported company-specific catalyst identified. - Searches found no...